NASDAQ:OGI

OrganiGram - OGI Stock Forecast, Price & News

$1.02

-0.13 (-10.87%)

(As of 12/6/2022 02:29 PM ET)

Add

Compare

Today's Range: $1.01
▼
$1.15
50-Day Range: $0.87
▼
$1.19
52-Week Range: $0.84
▼
$2.13

Volume: 101,730 shs
Average Volume: 1.18 million shs
Market Capitalization: $321.71 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $2.96

OrganiGram MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 193.1% Upside
$2.96 Price Target
Short Interest: Bearish
2.81% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.33
Based on 14 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.05) to ($0.02) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

669th out of 1,023 stocks

Pharmaceutical Preparations Industry

328th out of 501 stocks

3.5

Analyst's Opinion

Consensus Rating
OrganiGram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $2.96, OrganiGram has a forecasted upside of 193.1% from its current price of $1.01.
Amount of Analyst Coverage
OrganiGram has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.81% of the outstanding shares of OrganiGram have been sold short.
Short Interest Ratio / Days to Cover
OrganiGram has a short interest ratio ("days to cover") of 8.6.
Change versus previous month
Short interest in OrganiGram has recently increased by 2.67%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
OrganiGram does not currently pay a dividend.
Dividend Growth
OrganiGram does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OGI.

2.4

News and Social Media Coverage

News Sentiment
OrganiGram has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 14 news articles for OrganiGram this week, compared to 1 article on an average week.
Search Interest
Only 24 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -4% compared to the previous 30 days.
MarketBeat Follows
23 people have added OrganiGram to their MarketBeat watchlist in the last 30 days. This is an increase of 229% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OrganiGram insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 11.87% of the stock of OrganiGram is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for OrganiGram are expected to grow in the coming year, from ($0.05) to ($0.02) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of OrganiGram is -25.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of OrganiGram is -25.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
OrganiGram has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About OrganiGram (NASDAQ:OGI) Stock

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

December 2, 2022 | marketbeat.com

MarketBeat: Week in Review 11/28 – 12/02 (OGI)

Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week

November 29, 2022 | marketbeat.com

Three Reasons It’s Time To Get Bullish On Organigram

Organigram is getting closer and closer to true profits and there are other catalysts in the works that will boost revenue and profitability over the long term.

December 4, 2022 | americanbankingnews.com

FY2023 EPS Estimates for OrganiGram Holdings Inc. (NASDAQ:OGI) Cut by Alliance Global Partners

December 3, 2022 | americanbankingnews.com

Brokers Issue Forecasts for OrganiGram Holdings Inc.'s Q4 2023 Earnings (NASDAQ:OGI)

November 28, 2022 | finance.yahoo.com

Organigram Reports Record Fourth Quarter and Full Year Fiscal 2022 Results

November 26, 2022 | americanbankingnews.com

OrganiGram (OGI) Set to Announce Quarterly Earnings on Monday

November 23, 2022 | finance.yahoo.com

Organigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash Categories

October 16, 2022 | finance.yahoo.com

The past three years for OrganiGram Holdings (TSE:OGI) investors has not been profitable

October 13, 2022 | fool.com

2 Pot Stocks That Could Set You Up for Life - The Motley Fool

October 12, 2022 | nasdaq.com

Tilray Brands Stock Could Grow by 20 Times by 2030 - Nasdaq

October 6, 2022 | fool.com

Why Pot Stocks Like Canopy Growth and Organigram Surged Higher Today - The Motley Fool

September 15, 2022 | fool.com

1 Surprising Stat That Could Help Jump-Start This Struggling Sector - The Motley Fool

September 14, 2022 | benzinga.com

OrganiGram Holdings (NASDAQ:OGI), HEXO (NASDAQ:HEXO) – Want Exposure To The Canadian Recreational Cannabi - Benzinga

September 14, 2022 | seekingalpha.com

New congressional bill aims to empower small cannabis growers (NASDAQ:TLRY) - Seeking Alpha

September 8, 2022 | marketwatch.com

Quebec and Alberta provinces reportedly won't allow sales of Mike Tyson's cannabis by Hexo - MarketWatch

September 1, 2022 | fool.com

Why Pot Stocks Are Going Up In Smoke Today - The Motley Fool

August 31, 2022 | streetinsider.com

Canadian Cannabis Stocks To Watch In September - StreetInsider.com

August 18, 2022 | nasdaq.com

Organigram Holdings Inc. Common Shares (OGI)

July 27, 2022 | streetinsider.com

Top Canadian Cannabis Stocks To Watch Before August - StreetInsider.com

July 14, 2022 | fool.com

Here's What Moved Sundial Growers, Organigram, and Canopy Growth Stocks Today - The Motley Fool

July 14, 2022 | ca.investing.com

Organigram Holdings Reports Q2 Net Loss of $2.79M By Investing.com - Investing.com Canada

July 14, 2022 | seekingalpha.com

Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3 - Seeking Alpha

July 4, 2022 | fool.ca

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy! - The Motley Fool Canada

July 1, 2022 | ft.com

We should have limited empathy for the Big Boss resignation - Financial Times

June 24, 2022 | benzinga.com

Organigram Reaches Proposed Settlement In 2016 Class Action - Benzinga - Benzinga

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Company Calendar

Last Earnings: 7/12/2021
Today: 12/06/2022
Next Earnings (Estimated): 1/09/2023
Fiscal Year End: 8/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:OGI
CUSIP: N/A
CIK: 1620737
Web: www.organigram.ca
Phone: (844) 644-4726
Fax: N/A
Employees: 841
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $2.96
High Stock Price Forecast: $5.30
Low Stock Price Forecast: $1.50
Forecasted Upside/Downside: +188.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,230,000.00
Net Margins: -9.79%
Pretax Margin: -9.86%
Return on Equity: -7.46%
Return on Assets: -6.57%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.01
Quick Ratio: 2.77

Sales & Book Value

Annual Sales: $111.27 million
Price / Sales: 2.89
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.27 per share
Price / Book: 0.81

Miscellaneous

Outstanding Shares: 313,860,000
Free Float: N/A
Market Cap: $321.71 million
Optionable: Not Optionable
Beta: 0.75

Key Executives

Mr. Derrick W. West CPA (Age 55)
CPA, (CA), Chief Financial Officer
Comp: $231.81k

Ms. Helen Martin (Age 44)
Chief Legal Officer & Corp. Sec.
Comp: $217.11k

Mr. Gregory Engel (Age 57)
Special Advisor
Comp: $434.3k

Mr. Timothy Emberg
Chief Revenue Officer

Mr. Paolo De Luca C.A. (Age 49)
C.F.A, Chief Strategy Officer
Comp: $228.74k

Ms. Beena G. Goldenberg (Age 59)
CEO & Director

Ms. Nathalie Batten
VP of Operations

Amy Schwalm
VP of Investor Relations

Ms. Megan Amber McCrae
Sr. VP of Marketing & Communications

Tina Shannon
VP of HR

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OGI Stock - Frequently Asked Questions

Should I buy or sell OrganiGram stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings or view top-rated stocks.
What is OrganiGram's stock price forecast for 2023?: 4 equities research analysts have issued 1-year target prices for OrganiGram's shares. Their OGI share price forecasts range from $1.50 to $5.30. On average, they expect the company's share price to reach $2.96 in the next twelve months. This suggests a possible upside of 187.4% from the stock's current price.
View analysts price targets for OGI or view top-rated stocks among Wall Street analysts.
How have OGI shares performed in 2022?: OrganiGram's stock was trading at $1.75 on January 1st, 2022. Since then, OGI stock has decreased by 41.1% and is now trading at $1.03.
View the best growth stocks for 2022 here.
When is OrganiGram's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, January 9th 2023.
View our OGI earnings forecast.
How were OrganiGram's earnings last quarter?: OrganiGram Holdings Inc. (NASDAQ:OGI) issued its earnings results on Monday, July, 12th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.02. The company had revenue of $16.55 million for the quarter, compared to analyst estimates of $13.95 million. OrganiGram had a negative trailing twelve-month return on equity of 7.46% and a negative net margin of 9.79%.
What other stocks do shareholders of OrganiGram own?: Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is OrganiGram's stock symbol?: OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
Who are OrganiGram's major shareholders?: OrganiGram's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (4.29%), Renaissance Technologies LLC (0.30%), Two Sigma Advisers LP (0.15%), Connor Clark & Lunn Investment Management Ltd. (0.12%), Royal Bank of Canada (0.03%) and Group One Trading L.P. (0.00%).
How do I buy shares of OrganiGram?: Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is OrganiGram's stock price today?: One share of OGI stock can currently be purchased for approximately $1.03.
How much money does OrganiGram make?: OrganiGram (NASDAQ:OGI) has a market capitalization of $323.28 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.
How many employees does OrganiGram have?: The company employs 841 workers across the globe.
How can I contact OrganiGram?: OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 12/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial